Cart
sales@molnova.com
Phospho(enol)pyruvic acid monopotassium
CAS No. 4265-07-0
Phospho(enol)pyruvic acid monopotassium( PEP-K )
Catalog No. M19765 CAS No. 4265-07-0
Phosphoenolpyruvic acid monopotassium salt is involved in glycolysis and gluconeogeneis. In glycolysis PEP is metabolized by Pyruvate Kinase to yield pyruvate. In plants PEP is involved in the formation of aromatic amino acids as well as in the carbon fixation pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 41 | In Stock |
|
| 1G | 63 | In Stock |
|
Biological Information
-
Product NamePhospho(enol)pyruvic acid monopotassium
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhosphoenolpyruvic acid monopotassium salt is involved in glycolysis and gluconeogeneis. In glycolysis PEP is metabolized by Pyruvate Kinase to yield pyruvate. In plants PEP is involved in the formation of aromatic amino acids as well as in the carbon fixation pathway.
-
DescriptionPhosphoenolpyruvic acid monopotassium salt is involved in glycolysis and gluconeogeneis. In glycolysis PEP is metabolized by Pyruvate Kinase to yield pyruvate. In plants PEP is involved in the formation of aromatic amino acids as well as in the carbon fixation pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsPEP-K
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4265-07-0
-
Formula Weight206.13
-
Molecular FormulaC3H4KO6P
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[K+].OC(=O)C(=C)OP(O)([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4(15),5,10(14)-Germa...
4(15),5,10(14)-Germacratrien-1-ol is a natural product for research related to life sciences.
-
Prometryn
Prometryn is a triazine that can be used as a herbicide.
-
Ruplizumab
Ruplizumab (BG 9588), a humanized monoclonal IgG1κ antibody targeting CD40L (TNF Receptor), holds promise for research in systemic lupus erythematosus disease .
